BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10570095)

  • 1. Sustained reduction of hyperhomocysteinaemia with folic acid supplementation in predialysis patients.
    Jungers P; Joly D; Massy Z; Chauveau P; Nguyen AT; Aupetit J; Chadefaux B
    Nephrol Dial Transplant; 1999 Dec; 14(12):2903-6. PubMed ID: 10570095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma homocysteine, vitamin B6, vitamin B12 and folic acid in end-stage renal disease during low-dose supplementation with folic acid.
    Hong SY; Yang DH; Chang SK
    Am J Nephrol; 1998; 18(5):367-72. PubMed ID: 9730558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recommended dietary allowance of folic acid is insufficient for optimal homocysteine levels].
    Brouwer DA; Welten HT; van Doormaal JJ; Reijngoud DJ; Muskiet FA
    Ned Tijdschr Geneeskd; 1998 Apr; 142(14):782-6. PubMed ID: 9646611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperhomocysteinaemia, folate and vitamin B12 in unsupplemented haemodialysis patients: effect of oral therapy with folic acid and vitamin B12.
    Billion S; Tribout B; Cadet E; Queinnec C; Rochette J; Wheatley P; Bataille P
    Nephrol Dial Transplant; 2002 Mar; 17(3):455-61. PubMed ID: 11865092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, placebo-controlled trial of intramuscular vitamin B12 for the treatment of hyperhomocysteinaemia in dialysis patients.
    Polkinghorne KR; Zoungas S; Branley P; Villanueva E; McNeil JJ; Atkins RC; McGrath BP; Kerr PG
    Intern Med J; 2003 Nov; 33(11):489-94. PubMed ID: 14656250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.
    Jamison RL; Hartigan P; Kaufman JS; Goldfarb DS; Warren SR; Guarino PD; Gaziano JM;
    JAMA; 2007 Sep; 298(10):1163-70. PubMed ID: 17848650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of long-term intravenous high dose B-complex vitamins with or without folic acid on serum homocysteine in hemodialysis patients.
    Sombolos K; Fragia T; Natse T; Bartholomatos G; Karagianni A; Katsaris G; Christidou F; Bamichas G; Stangou M; Papagalanis N
    J Nephrol; 2002; 15(6):671-5. PubMed ID: 12495282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of methylcobalamin on lowering total homocysteine plasma concentrations in haemodialysis patients receiving high-dose folic acid supplementation.
    Koyama K; Usami T; Takeuchi O; Morozumi K; Kimura G
    Nephrol Dial Transplant; 2002 May; 17(5):916-22. PubMed ID: 11981084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homocysteine lowering effect of different multivitamin preparations in patients with end-stage renal disease.
    Dierkes J; Domröse U; Bosselmann KP; Neumann KH; Luley C
    J Ren Nutr; 2001 Apr; 11(2):67-72. PubMed ID: 11295026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins.
    Tremblay R; Bonnardeaux A; Geadah D; Busque L; Lebrun M; Ouimet D; Leblanc M
    Kidney Int; 2000 Aug; 58(2):851-8. PubMed ID: 10916110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid and pyridoxal-5'-phosphate losses during high-efficiency hemodialysis in patients without hydrosoluble vitamin supplementation.
    Leblanc M; Pichette V; Geadah D; Ouimet D
    J Ren Nutr; 2000 Oct; 10(4):196-201. PubMed ID: 11070147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V; Kes P; Zeljko R; Kusec V
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperhomocysteinaemia therapy in haemodialysis patients: folinic versus folic acid in combination with vitamin B6 and B12.
    Ducloux D; Aboubakr A; Motte G; Toubin G; Fournier V; Chalopin JM; Drüeke T; Massy ZA
    Nephrol Dial Transplant; 2002 May; 17(5):865-70. PubMed ID: 11981075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Frequency of hyperhomocysteinemia in hemodialysis patients with folic acid supplementation].
    Kárpáti I; Balla J; Szóke G; Bereczky Z; Páll D; Ben T; Toma K; Katona E; Mohácsi A; Paragh G; Varga Z; Kakuk G; Muszbek L
    Orv Hetil; 2002 Jul; 143(27):1635-40. PubMed ID: 12180000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients.
    Azadibakhsh N; Hosseini RS; Atabak S; Nateghiyan N; Golestan B; Rad AH
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):779-88. PubMed ID: 19736473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin B12 and folic acid supplementation and plasma total homocysteine concentrations in pregnant Indian women with low B12 and high folate status.
    Katre P; Bhat D; Lubree H; Otiv S; Joshi S; Joglekar C; Rush E; Yajnik C
    Asia Pac J Clin Nutr; 2010; 19(3):335-43. PubMed ID: 20805077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid and vitamin B12 are more effective than vitamin B6 in lowering fasting plasma homocysteine concentration in patients with coronary artery disease.
    Lee BJ; Huang MC; Chung LJ; Cheng CH; Lin KL; Su KH; Huang YC
    Eur J Clin Nutr; 2004 Mar; 58(3):481-7. PubMed ID: 14985687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of homocysteine levels in coronary artery disease by low-dose folic acid combined with vitamins B6 and B12.
    Lobo A; Naso A; Arheart K; Kruger WD; Abou-Ghazala T; Alsous F; Nahlawi M; Gupta A; Moustapha A; van Lente F; Jacobsen DW; Robinson K
    Am J Cardiol; 1999 Mar; 83(6):821-5. PubMed ID: 10190392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of the genomic damage level in haemodialysis patients by folic acid and vitamin B12 supplementation.
    Stopper H; Treutlein AT; Bahner U; Schupp N; Schmid U; Brink A; Perna A; Heidland A
    Nephrol Dial Transplant; 2008 Oct; 23(10):3272-9. PubMed ID: 18469307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
    Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
    J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.